As shown by Tijtgat et al., BDCA-1+, as well as BDCA-3+ myDCs, are able to mature and engulf tumor fragments of T-VEC treated melanoma cells and subsequently cross-present tumor antigens toward antigen-specific T cells [29]. The gene discussed is CD1C; the disease is neoplasm.